During a recent episode of "The Future of Everything," host Russ Altman and guest Ami Bhatt discuss the factors that contribute to microbiome health.
A Stanford scientist and his son harness RNA sequencing to discover the genomic mutation behind the uncommon California poppy.
A new study finds chronic irradiation causes physiological and behavioral deficits in mice, pointing to potential health risks to humans traveling to Mars.
Stanford scientists have found 16 new genetic variants linked to a greater risk for autism, a finding that could help identify biomarkers for the disorder.
The bacteria in our gut make tiny, previously unidentified proteins that could shed light on human health and advance drug development.
Stanford researchers discover a gel that, when applied to animal hearts, vastly reduces the formation of adhesions, scar tissue that cause complications.
A new Stanford study in children with autism showed the value of teaching parents how to use everyday interactions to motivate their children to speak.
Stanford postdoc Arnold Mathijssen wanted to know how bacteria swim upstream. Someday, his findings could shape how we design devices and deliver drugs.
Scientists at Stanford have identified a gene key to the formation of a type of toxic protein in amyotrophic lateral sclerosis, a neurodegenerative disease.
Researchers at Stanford have created an algorithm that predicts how likely CRISPR gene editing will yield off-target mutations.
In a recent Stanford podcast, food allergy expert Kari Nadeau explains the latest research on predicting, preventing and treating allergies.
This In the Spotlight features Helio Costa, a geneticist who has developed an assay currently being used to help cancer patients.
Stanford researchers are developing scientific discovery games that allow players to contribute to experimental laboratory science.
Stanford researchers watch in real time bacteria building their protective outer shell. Their findings may help develop treatments for bacterial pathogens.
Frustrated by the poor options for their patients, two neurosurgery residents left to study basic science at Stanford, developing a drug for brain tumors.
The real question a new study suggests, isn't why some people occasionally experience hallucinations: It's why all of us aren't hallucinating all the time.
